Hypothesis\n\nCore claim: The phosphorylation state of selective autophagy receptors (e.g., p62/SQSTM1, NBR1, OPTN) is under circadian control and dictates the order in which specific organelles are targeted for autophagic degradation. Misalignment of this circadian gating—caused by sleep deprivation, shift work, or mistimed nutrition—scrambles the autophagy hierarchy, leading to preferential clearance of low‑priority cargo while high‑risk substrates (damaged mitochondria, ER‑stressed proteins, α‑synuclein aggregates) accumulate, thereby accelerating age‑related decline.\n\n## Mechanistic Rationale\n\n- Autophagy receptors contain LC3‑interacting regions (LIR) and ubiquitin‑binding domains that are modulated by phosphorylation (e.g., p62 Ser403, Ser407) which alters affinity for distinct ubiquitin chain types (K63 vs K48) and thus substrate preference 1.\n- Clock‑controlled kinases such as GSK3β and CK1δ exhibit rhythmic activity, imposing a daily rhythm on receptor phosphorylation 2. This creates a temporal window where mitochondria‑associated receptors are primed, followed later by ER‑associated receptors.\n- When the circadian signal is dampened (e.g., reduced amplitude of PER2), phosphorylation becomes constitutively low or high, biasing receptor affinity toward a single ubiquitin linkage and freezing the hierarchy.\n- Consequently, under chronic misalignment, cells repeatedly “eat” the same substrate class (e.g., cytosolic proteins) while neglecting organelle quality control, resulting in accumulation of ROS‑producing mitochondria and inflammasome‑activating aggregates.\n\n## Testable Predictions\n\n1. Phospho‑rhythm correlation: In human PBMCs, the ratio of phospho‑p62 (Ser403) to total p62 will show a 24‑h oscillation that aligns with individual melatonin onset (DLMO) measured via saliva. Individuals with flattened phospho‑rhythm will exhibit higher mitochondrial ROS (MitoSOX) and lower ATP‑linked respiration in parallel PBMC assays.\n2. Wearable linkage: Oura‑derived HRV nadir and resting heart rate will predict the phase angle of the phospho‑p62 rhythm; a phase delay >2 h will correspond to a shift in autophagy hierarchy toward preferential p62‑K48 binding (measured by ubiquitination pull‑down) and increased LC3‑II accumulation after an acute fasting challenge.\n3. Intervention rescue: Timed administration of a GSK3β inhibitor (e.g., tideglusib) at the subjective biological night will restore normal phospho‑p62 oscillation in shift‑workers, leading to:\n - Increased mitophagy flux (measured by mt‑Keima reporter in isolated monocytes)\n - Decreased cytosolic α‑synuclein aggregation (filter‑trap assay)\n - Improved next‑day Oura recovery score (≥10 % increase in HRV balance) relative to placebo.\n\n## Experimental Design (Human Pilot)\n\n- Participants: 30 healthy adults stratified by self‑reported sleep regularity (regular vs irregular).\n- Protocol: 7‑day baseline wearables (Oura), twice‑daily saliva melatonin, and four‑hourly PBMC draws over 24 h on day 4.\n- Assays: Western blot for total p62, phospho‑p62 (Ser403/Ser407), ubiquitin chain linkages (K63 vs K48) immunoprecipitated with p62; LC3‑II/I ratio; mitochondrial ROS; Seahorse OCR.\n- Analysis: Cosinor fitting to determine amplitude, acrophase, and MESST of phospho‑p62; correlate with wearable metrics via linear mixed models; test interaction with timed tideglusib (crossover, 2 days on/off) on day 8‑9.\n\n## Falsifiability\n\nIf phospho‑p62 rhythm shows no relationship to wearable HRV/DLMO, or if restoring phosphorylation does not alter mitophagy flux or recovery scores, the hypothesis is falsified. Conversely, a positive correlation and rescue would support the notion that circadian gating of autophagy receptor hierarchy is a mechanistic link between behavior‑driven stressors and cellular aging.\n\n## Broader Impact\n\nLinking a molecular “cannibalism ritual” to real‑time wearable data enables personalized prescriptions: adjusting meal timing, light exposure, or pharmacological modulators to keep the autophagy hierarchy in sync with an individual’s circadian phase, thereby delaying the accumulation of selective damage that drives age‑related pathology.